<DOC>
	<DOCNO>NCT00706251</DOCNO>
	<brief_summary>For patient chronic epiphora , Dacryocystorhinostomy currently gold standard treatment , success rate 80-90 % accord literature . Another available treatment , far less used , nasolacrimal intubation , use silicone tube . In study , would like find efficacy nasolacrimal duct intubation , perform medical center hundred patient mild epiphora . Study hypothesis : nasolacrimal intubation adult , clinically mild epiphora , close 's efficacy Dacryocystorhinostomy procedure .</brief_summary>
	<brief_title>Follow Nasolacrimal Intubation Adults</brief_title>
	<detailed_description>Under normal condition , amount tear excrete lacrimal gland eye equal amount drain tear duct . Epiphora adult usually involve blockage lacrimal sac nasolacrimal duct . Epiphora cause tear patient , treat sympthomatically conservative way ( antibiotic treatment , probe tear duct , pressure irrigation tear duct ) therapeutic invasive way . The invasive treatment include one following : 1 . Dacryocystorhinostomy - surgery reconstruct alternative path tear drainage . 2 . Nasolacrimal intubation - insert silicone tube tear duct . The tube usually remove 3-6 month . Currently , report regard efficacy nasolacrimal intubation , small number research subject . Also , report stratify patient accord location tear duct blockage , n't take account severity blockage ( ie severity symptom ) prior perform intubation . In research , would like find efficacy nasolacrimal intubation perform medical center hundred patient mild epiphora , compare efficacy Dacryocystorhinostomy - 80-90 % accord literature .</detailed_description>
	<mesh_term>Lacrimal Apparatus Diseases</mesh_term>
	<mesh_term>Dacryocystitis</mesh_term>
	<criteria>Clinical diagnosis mild epiphora . Underwent nasolacrimal intubation 01/2000 12/2007 . Purulent excretion nasolacrimal duct day admission intubation . Nasolacrimal intubation past . Dacryocystorhinostomy past .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>